Research Article


DOI :10.26650/IstanbulJPharm.2020.0041   IUP :10.26650/IstanbulJPharm.2020.0041    Full Text (PDF)

Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit

Nesligül ÖzdemirAyçe ÇelikerBülent Barış KuşkonmazDuygu Uçkan Çetinkaya

Background and Aims: Many drugs with narrow therapeutic range and high toxicity risk are used in hematopoietic stem cell transplantation (HSCT) Units. The increase in the number of drugs raises the likelihood of interactions. This is particularly important in pediatric patients and may adversely affect the treatment process. In this study, we aimed to determine the potential drug interactions and to evaluate the clinical significance of them in terms of physician’s and pharmacist’s perceptions. Methods: The study was conducted as a prospective descriptive study over a six-month period in a tertiary care hospital’s Pediatric HSCT Unit. A pharmacist evaluated inpatients’ drugs for drug interactions by using a drug interaction checker program and the clinical significance of the interactions were evaluated by the physician and the pharmacist separately. Results: Drugs used in 20 patients (median age= 8 years, range= 0.6–17 years) were evaluated. A total of 525 potential drugdrug interactions were identified. Two hundred and forty seven interactions (47.05%) were major; 238 (45.33%) were moderate; 23 (4.38%) were contraindicated. The number of the interactions considered “clinically significant” by the pharmacist and “clinically insignificant” by the physician at the preparative regimen and post-transplant period were 15 (35.7%) and 37 (29.4%), respectively. Conclusion: The management of drug interactions is important in pediatric HSCT patients as a vulnerable group. Drug interactions should be interpreted according to the patient's clinical presentation, not only theoretically. Cooperation between physicians and pharmacists in the management of interactions will contribute to optimize the patient's treatment.


PDF View

References

  • Aljadani, R., & Aseeri, M. (2018). Prevalence of drug-drug interactions in geriatric patients at an ambulatory care pharmacy in a tertiary care teaching hospital. BMC Research Notes, 11(1). http:// dx.doi.org 10.1186/s13104-018-3342-5 google scholar
  • Ament, P. W., Bertolino, J.G., & Liszewski, J.L. (2000). Clinically significant drug interactions. American Family Physician, 61(6), 1745–1754. google scholar
  • Balk, T. E., Van-der-Sijs, I. H., Van-Gelder, T., Janssen, J. J. B., Van-der Sluis IM, Van-Leeuwen, R. W. F., & Engels, F. K. (2017). Drug-drug interactions in pediatric oncology patients. Pediatric Blood Cancer. 64(7). https://doi.org/10.1002/pbc.26410 google scholar
  • Bernard, E., Goutelle, S., Bertrand, Y., & Bleyzac, N. (2014). Pharmacokinetic drug-drug interaction of calcium channel blockers with cyclosporine in hematopoietic stem cell transplant children. Annals of Pharmacotherapy, 48(12), 1580–1584. https://doi. org/ 10.1177/1060028014550644 google scholar
  • Campana, C., Regazzi, M. B, Buggia, I., & Molinaro, M. (1996). Clinically significant drug interactions with cyclosporin - An update. Clinical Pharmacokinetics, 30(2), 141–179. google scholar
  • Chan, A., Tan, S. H., Wong, C. M., Yap, K. Y., & Ko, Y. (2009). Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists. Clinical Therapeutics, 31(2), 2379–2386. https://doi. org/10.1016/j.clinthera.2009.11.008 google scholar
  • Deeg, H. J. (2005). Optimization of transplant regimens for patients with myelodysplastic syndrome (MDS). Hematology American Society of Hematology Education Program, 167–173. google scholar
  • Eldesouky, H. E., Li, X., Abutaleb, N. S., Mohammad, H., & Seleem, M. N. (2018). Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris. International Journal of Antimicrobial Agents, 52(6), 754–761. https://doi.org/10.1016/j.ijantimicag.2018.08.016 google scholar
  • Gholaminezhad, S., Hadjibabaie, M., Gholami, K., Javadi, M. R., Radfar, M., Karimzadeh, I., & Ghavamzadeh, A. (2014). Pattern and associated factors of potential drug-drug interactions in both preand early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East. Annals of Hematology, 93(11), 1913–1922. google scholar
  • Glotzbecker, B., Duncan, C., Alyea, E., Campbell, B., & Soiffer, R. (2012). Important drug interactions in hematopoietic stem cell transplantation: what every physician should know. Biology of Blood and Marrow Transplantation, 18(7), 989–1006. https://doi. org/ 10.1016/j.bbmt.2011.11.029 google scholar
  • Leather, H. L. (2004). Drug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know. Bone Marrow Transplantation, 33(2), 137–152. google scholar
  • Marcath, L. A., Coe, T. D., Hoylman, E. K., Redman, B. G., & Hertz, D. L. (2018). Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials. BMC Cancer, 18(1), 1155-1163. http://dx.doi.org/10.1186/ s12885-018-5076-0 google scholar
  • Metzke, B., Hug, M. J., Fink, G., Hieke, S., Jung, M., & Engelhardt, M. (2012). Drug-drug interactions in the hematology and oncology department: a real-life assessment of frequency and severity. Blood, 120(21), 4250–4250. Retrieved from https://www.researchgate.net/publication google scholar
  • Myers, A. L., Kawedia, J. D., Champlin, R. E., Kramer, M. A., Nieto, Y., Ghose, R., & Andersson, B. S. (2017). Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review. Expert Opinion on Drug Metabolism& Toxicology, 13(9), 901–923. https://doi.org/ 10. 1080/17425255.2017.1360277 google scholar
  • Prot-Labarthe, S., Therrien, R., Demanche, C., Larocque, D., & Bussieres, J. F. (2008). Pharmaceutical care in an inpatient pediatric hematopoietic stem cell transplant service. Journal of Oncology Pharmacy Practice, 14(3), 147–152. https://doi. org/ 10.1177/1078155208093929 google scholar
  • Rodrigues, A. T., Stahlschmidt, R., Granja, S., Pilger, D., Falcao, A. L. E., & Mazzola, P. G. (2017). Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital. Brazilian Journal of Pharmaceutical Science, 53(1), e16109- e16117. https://doi.org/10.1590/s2175-97902017000116109 google scholar
  • Sadaba, B., Lopez-de-Ocariz, A., Azanza, J. R., Quiroga, J., & Cienfuegos, J. A. (1998). Concurrent clarithromycin and cyclosporin A treatment. Journal of Antimicrobial Chemotherapy, 42(3), 393–395. google scholar
  • Sanchez, L., Bacle, A., Lamy, T., & Le-Corre, P. (2019) Potential drugdrug interactions and nephrotoxicity in hematopoietic stem cell transplant adult recipients during bone marrow transplantation unit stay. Cancer Chemotherapy and Pharmacology, 83(5), 827– 835. https://doi.org/10.1007/s00280-019-03791-9. google scholar
  • Tavousi, F., Sadeghi, A., Darakhshandeh, A., & Moghaddas, A. (2019). Potential drug-drug interactions at a referral pediatric oncology ward in Iran: A cross-sectional study. Journal of Pediatric Hematology Oncology, 41(3), e146–e151. https://doi.org/10.1097/ MPH.0000000000001346 google scholar
  • Trevisan, D. D., Silva, J. B., Oliveira, H. C., Secoli, S. R., & Lima, M. H. (2015). Prevalence and clinical significance of potential drugdrug interaction in hematopoietic stem cell transplantation. Cancer Chemotherapy and Pharmacology, 75(2), 393–400. https://doi. org/10.1007/s00280-014-2657-8 google scholar
  • Valenzuela, R., Torres, J. P., Salas, C., Gajardo, I., Palma, J., Catalan, P. … Morales, J. (2017). Drug interaction of voriconazole-cyclosporine in children undergoing hematopoietic stem cell transplantation (2013-2014). Revista Chilena de Infectologia, 34(1), 14–18. https://doi.org/ 10.4067/s0716-10182017000100002 google scholar
  • Zeighami, S., Hadjibabaie, M., Ashouri, A., Sarayani, A., Khoee, S. H., Mousavi, S. … Ghavamzadeh, A. (2014). Assessment of cyclosporine serum concentrations on the incidence of acute graft versus host disease post hematopoietic stem cell transplantation. Iranian Journal of Pharmaceutical Research, 13(1), 305–312. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Özdemir, N., Çeliker, A., Kuşkonmaz, B.B., & Uçkan Çetinkaya, D. (2021). Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit. İstanbul Journal of Pharmacy, 51(1), 1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041


AMA

Özdemir N, Çeliker A, Kuşkonmaz B B, Uçkan Çetinkaya D. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit. İstanbul Journal of Pharmacy. 2021;51(1):1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041


ABNT

Özdemir, N.; Çeliker, A.; Kuşkonmaz, B.B.; Uçkan Çetinkaya, D. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit. İstanbul Journal of Pharmacy, [Publisher Location], v. 51, n. 1, p. 1-7, 2021.


Chicago: Author-Date Style

Özdemir, Nesligül, and Ayçe Çeliker and Bülent Barış Kuşkonmaz and Duygu Uçkan Çetinkaya. 2021. “Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit.” İstanbul Journal of Pharmacy 51, no. 1: 1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041


Chicago: Humanities Style

Özdemir, Nesligül, and Ayçe Çeliker and Bülent Barış Kuşkonmaz and Duygu Uçkan Çetinkaya. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit.” İstanbul Journal of Pharmacy 51, no. 1 (Jun. 2021): 1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041


Harvard: Australian Style

Özdemir, N & Çeliker, A & Kuşkonmaz, BB & Uçkan Çetinkaya, D 2021, 'Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit', İstanbul Journal of Pharmacy, vol. 51, no. 1, pp. 1-7, viewed 25 Jun. 2021, https://doi.org/10.26650/IstanbulJPharm.2020.0041


Harvard: Author-Date Style

Özdemir, N. and Çeliker, A. and Kuşkonmaz, B.B. and Uçkan Çetinkaya, D. (2021) ‘Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit’, İstanbul Journal of Pharmacy, 51(1), pp. 1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041 (25 Jun. 2021).


MLA

Özdemir, Nesligül, and Ayçe Çeliker and Bülent Barış Kuşkonmaz and Duygu Uçkan Çetinkaya. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit.” İstanbul Journal of Pharmacy, vol. 51, no. 1, 2021, pp. 1-7. [Database Container], https://doi.org/10.26650/IstanbulJPharm.2020.0041


Vancouver

Özdemir N, Çeliker A, Kuşkonmaz BB, Uçkan Çetinkaya D. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit. İstanbul Journal of Pharmacy [Internet]. 25 Jun. 2021 [cited 25 Jun. 2021];51(1):1-7. Available from: https://doi.org/10.26650/IstanbulJPharm.2020.0041 doi: 10.26650/IstanbulJPharm.2020.0041


ISNAD

Özdemir, Nesligül - Çeliker, Ayçe - Kuşkonmaz, BülentBarış - Uçkan Çetinkaya, Duygu. Evaluation of drug-drug interactions and their clinical importance in a pediatric hematopoietic stem cell transplantation unit”. İstanbul Journal of Pharmacy 51/1 (Jun. 2021): 1-7. https://doi.org/10.26650/IstanbulJPharm.2020.0041



TIMELINE


Submitted30.04.2020
Accepted29.09.2020
Published Online30.04.2021

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.